Sectoral Asset Management Inc

Search
⚲

Sectoral Asset Management Inc ✚
CRD #	110345
SEC #	801-60079
CIK #	0001274413
AUM	331.4 M (2026-05-06)
Employees	20 (55% Investors, 0% Brokers)
Fees
Minimum
Phone	514-849-8777
Address	1010 Sherbrooke Street, West Montreal Quebec, Canada
Source	[IAPD] [EDGAR] [Website] [LinkedIn]

Total AUM ($B) Copy

CIK	Period
0001274413	2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31

CIK

Period

0001274413

Sector	Form 13F Holdings	Value ($B)
	Evommune Inc	0.0
	Contineum Therapeutics Inc	0.0
	Shoulder Innovations Inc	0.0
	Lilly Eli & Co	0.0
	Johnson & Johnson	0.0
	Gilead Sciences Inc	0.0
	UnitedHealth Group Inc	0.0
	Amgen Inc	0.0
	Vertex Pharmaceuticals Inc / Ma	0.0
	Insmed Inc	0.0
	Argenx SE	0.0
	AbbVie Inc	0.0
	Abbott Laboratories	0.0
	Merck & Co Inc	0.0
	Regeneron Pharmaceuticals Inc	0.0
	Intuitive Surgical Inc	0.0
	Boston Scientific Corp	0.0
	Biontech SE	0.0
	Stryker Corp	0.0
	Danaher Corp /DE/	0.0
	Thermo Fisher Scientific Inc	0.0
	Dexcom Inc	0.0
	Quintiles Transnational Holdings Inc	0.0
	Summit Therapeutics PLC	0.0
	Edwards Lifesciences Corp	0.0
	Bristol Myers Squibb Co	0.0
	United Therapeutics Corp	0.0
	Vera Therapeutics Inc	0.0
	Arcus Biosciences Inc	0.0
	Roivant Sciences Ltd	0.0
Prev \| Page 1 \| Next

Type	Form D Funds	Date	AUM
PE	New Emerging Medical Opportunities Fund VI SCSP	2026-03-26	40.6 M
PE	New Emerging Medical Opportunities Fund V SCSP	2022-03-31	97.4 M
PE	New Emerging Medical Opportunities Fund IV SCSP	2019-03-29	72.4 M
PE	New Emerging Medical Opportunities Fund III LP	2016-03-29	2.2 M
Other	Sectoral Emerging Markets Healthcare Fund LP	[2016-03-29]
	Filed 2018-08-28 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
PE	New Emerging Medical Opportunities Fund II LP	2014-03-31	32.8 M
PE	New Emerging Medical Opportunities Fund LP	2012-03-30	4.0 M

AUM Breakdown	Accounts	AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	7	0.3
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	8	0.3
By Discretionary
Discretionary	8	0.3
Non-Discretionary	0	0.0
Total	8	0.3
By Non-United States Persons
Non-United States Persons		0.3
United States Persons		0.0
Total	8	0.3

Form D Directors	Role	# Filings	# Firms	2011 - 2026
Partners Ltd Sectoral Asset Management	Executive Officer	1	1

EDGAR Form	CIK	2011 - 2026
13F-HR	[0001274413]
SC 13G	[0001274413]

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Sectoral Asset Management Inc	Contineum Therapeutics Inc	[2024-11-14]
Sectoral Asset Management Inc	Galera Therapeutics Inc	[2023-02-13]
Sectoral Asset Management Inc	Effector Therapeutics Inc	[2022-02-11]
Sectoral Asset Management Inc	Aprea Therapeutics Inc	[2020-02-13]
Sectoral Asset Management Inc	La Jolla Pharmaceutical Co	[2019-02-13]
Sectoral Asset Management Inc	Collegium Pharmaceutical Inc	[2017-02-10]
Sectoral Asset Management Inc	Advaxis Inc	[2016-02-12]
Sectoral Asset Management Inc	OncoMed Pharmaceuticals Inc	[2015-02-13]
Sectoral Asset Management Inc	Amicus Therapeutics Inc	[2015-02-13]
Sectoral Asset Management Inc	Ironwood Pharmaceuticals Inc	[2014-02-11]
View All

Firm Profile (Form ADV)
Discretionary AUM	$3.3B
Serves	Institutional, Retail
Fund Types	Private Equity
LEI	254900KAKORD58ODPG76

Comparable Firms	State	AUM
LYNK Capital Management Company LLC ✚	FL	359.6 M
Twin Point Capital LLC ✚	NY	355.9 M
Cottonwood Ventures LLC ✚	TX	347.3 M
Millennial Advisers LLC ✚	NY	339.4 M
OCM Private Wealth LLC ✚	IL	338.1 M
Weik Capital Management Inc ✚	PA	334.7 M
Boston Family Advisors LLC ✚	MA	329.7 M
M4A3 LLC ✚	CO	322.0 M
Impact Investors Inc ✚		318.2 M
Adalta Capital Management LLC ✚	NY	305.5 M

{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}

Sectoral Asset Management Inc

Assets, Funds, Holdings